{
  "trial_id": "NCT02552888",
  "trial_group": "chronic kidney disease",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race/ethnicity, estimated glomerular filtration rate (eGFR), urinary albumin to creatinine ratio, protein to creatinine ratio, systolic blood pressure, diastolic blood pressure, history of myocardial infarction, history of cerebrovascular accident, history of transient ischemic attack, hemoglobin level, history of chronic obstructive pulmonary disease (COPD), glucose-6-phosphate dehydrogenase (G6PD) deficiency status, smoking status, alcohol or substance abuse status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race/ethnicity"
        ],
        [
          "Baseline Estimated Glomerular Filtration Rate of Study Participants by Treatment Allocation",
          "estimated glomerular filtration rate (eGFR)"
        ],
        [
          "Baseline Blood Pressure of Study Participants by Treatment Allocation",
          "systolic blood pressure"
        ],
        [
          "Baseline Blood Pressure of Study Participants by Treatment Allocation",
          "diastolic blood pressure"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment",
        "Baseline Metabolic Panel of Study Participants by Treatment Allocation",
        "Baseline Body Mass Index of Study Participants by Treatment Allocation"
      ],
      "remaining_candidate_features": [
        "urinary albumin to creatinine ratio",
        "protein to creatinine ratio",
        "history of myocardial infarction",
        "history of cerebrovascular accident",
        "history of transient ischemic attack",
        "hemoglobin level",
        "history of chronic obstructive pulmonary disease (COPD)",
        "glucose-6-phosphate dehydrogenase (G6PD) deficiency status",
        "smoking status",
        "alcohol or substance abuse status."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Estimated Glomerular Filtration Rate (eGFR), Urinary Albumin to Creatinine Ratio, Protein to Creatinine Ratio, Systolic Blood Pressure, Diastolic Blood Pressure, Hemoglobin,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Baseline Estimated Glomerular Filtration Rate of Study Participants by Treatment Allocation",
          "Estimated Glomerular Filtration Rate (eGFR)"
        ],
        [
          "Baseline Blood Pressure of Study Participants by Treatment Allocation",
          "Systolic Blood Pressure"
        ],
        [
          "Baseline Blood Pressure of Study Participants by Treatment Allocation",
          "Diastolic Blood Pressure"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Baseline Metabolic Panel of Study Participants by Treatment Allocation",
        "Baseline Body Mass Index of Study Participants by Treatment Allocation"
      ],
      "remaining_candidate_features": [
        "Urinary Albumin to Creatinine Ratio",
        "Protein to Creatinine Ratio",
        "Hemoglobin"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, eGFR, Systolic Blood Pressure, Diastolic Blood Pressure, Urinary Albumin to Creatinine Ratio, Protein to Creatinine Ratio, Hemoglobin, History of Cardiovascular Disease, Smoking Status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Baseline Estimated Glomerular Filtration Rate of Study Participants by Treatment Allocation",
          "eGFR"
        ],
        [
          "Baseline Blood Pressure of Study Participants by Treatment Allocation",
          "Systolic Blood Pressure"
        ],
        [
          "Baseline Blood Pressure of Study Participants by Treatment Allocation",
          "Diastolic Blood Pressure"
        ],
        [
          "Baseline Metabolic Panel of Study Participants by Treatment Allocation",
          "Urinary Albumin to Creatinine Ratio"
        ],
        [
          "Baseline Metabolic Panel of Study Participants by Treatment Allocation",
          "Protein to Creatinine Ratio"
        ]
      ],
      "remaining_reference_features": [
        "Baseline Body Mass Index of Study Participants by Treatment Allocation"
      ],
      "remaining_candidate_features": [
        "Hemoglobin",
        "History of Cardiovascular Disease",
        "Smoking Status"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race/ethnicity, eGFR, urinary albumin to creatinine ratio, protein to creatinine ratio, systolic BP, diastolic BP, body mass index (BMI), smoking status, medical history (including diabetes, hypertension, cardiovascular disease), medication use (including antihypertensive, lipid-lowering, and antiplatelet agents), hemoglobin, glucose-6-phosphate dehydrogenase (G6PD) status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race/ethnicity"
        ],
        [
          "Baseline Estimated Glomerular Filtration Rate of Study Participants by Treatment Allocation",
          "eGFR"
        ],
        [
          "Baseline Blood Pressure of Study Participants by Treatment Allocation",
          "systolic BP"
        ],
        [
          "Baseline Body Mass Index of Study Participants by Treatment Allocation",
          "body mass index (BMI)"
        ],
        [
          "Baseline Blood Pressure of Study Participants by Treatment Allocation",
          "diastolic BP"
        ],
        [
          "Baseline Metabolic Panel of Study Participants by Treatment Allocation",
          "urinary albumin to creatinine ratio"
        ],
        [
          "Baseline Metabolic Panel of Study Participants by Treatment Allocation",
          "protein to creatinine ratio"
        ],
        [
          "Baseline Metabolic Panel of Study Participants by Treatment Allocation",
          "hemoglobin"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "smoking status",
        "medical history (including diabetes, hypertension, cardiovascular disease)",
        "medication use (including antihypertensive, lipid-lowering, and antiplatelet agents)",
        "glucose-6-phosphate dehydrogenase (G6PD) status."
      ]
    }
  }
}